Friday, April 17, 2026
10:00 a.m. to 4:30 p.m. ET
Online Only
**The agenda is tentative and subject to change.**
« Back to Workshop Page
«« See Day 1: April 15, 2026
« See Day 2: April 16, 2026
10:00 a.m.
Opening Remarks and Day 2 Recap
Workshop and Panel Chair
Director’s Remarks
10:10 a.m.
National Institute of Mental Health
Andrea Beckel-Mitchener, Ph.D.
Acting Director, National Institute of Mental Health
National Institutes of Health
10:15 a.m.
National Heart, Lung, and Blood Institute
TBD
Senior Leadership
National Heart, Lung, and Blood Institute
National Institutes of Health
Key Question 2a:
What is the impact of individual-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms? Individual-level factors include, but are not limited to, educational attainment, patient engagement in health care, lifestyle factors, and comorbidities.
10:20 a.m.
Moderator Perspectives—Genevieve Neal-Perry, M.D., Ph.D.
10:30 a.m.
Patient Education: Menopause Preparedness—Irene Aninye, Ph.D.
10:50 a.m.
Provider Education: Training for Patient Centered Care of Menopause—Rajita G. Patil, M.D.
11:10 a.m.
Community Engagement: Perspectives on Advocacy and Empowerment—Genevieve Neal-Perry, M.D., Ph.D.
11:30 a.m.
Awareness/Communications—Jennifer Gunter, M.D.
11:50 a.m.
Discussion
Moderated by
Genevieve Neal-Perry, M.D., Ph.D.
12:10 p.m.
Lunch Break
Key Question 2b
What is the impact of system-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms? System-level factors include, but are not limited to, racism, provider bias, access to care, and social determinants of health. Do the effectiveness, comparative effectiveness, and harms of treatment vary by individual- or system-level factors?
12:40 p.m.
Bench to Bedside Perspectives: System-Level Measurement Challenges—Andrea LaCroix, Ph.D.
1:00 p.m.
Bedside to Community Perspectives: Regulatory Challenges—Janet Maynard, M.D.
1:20 p.m.
Menopause in Cultural Context—Yamnia Cortes, Ph.D., M.P.H., RN, FAHA, FAAN
1:40 p.m.
Discussion
Moderated by
Workshop & Panel Chair
2:00 p.m.
Break
General Session 3
Innovative Approaches to Symptom Prevention and Management: Walk Before We Run—Grounding Innovation in Evidence for Menopause Care
2:10 p.m.
Moderator Perspectives—Melissa S. Wong, M.D., M.H.D.S.
2:20 p.m.
Data Gaps and the DREAMS Registry—Stephanie S. Faubion, M.D., M.B.A.
2:35 p.m.
Sexual Health and Direct-to-Consumer Approaches—Lyndsey Harper, M.D.
2:50 p.m.
Health Policy and Digital Innovation Readiness—Barbara Levy, M.D., FACOG, FACS
3:05 p.m.
Spread of Misinformation—Jevin West, Ph.D.
3:20 p.m.
Discussion
Moderated by
Melissa S. Wong, M.D., M.H.D.S.
3:40 p.m.
Break
3:50 p.m.
What We Learned, What Comes Next?
Moderated by
Sarah Temkin, M.D.
4:20 p.m.
Closing Remarks & Next Steps
Workshop and Panel Chair
Keisha Shropshire, M.P.H.
P2P Workshop Coordinator
4:30 p.m.
Adjourn